Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Sparsentan is a first-in-class orally active and highly potent dual endothelin A and angiotensin II receptor antagonist(Ki of 9.3 and 0.8 nM, respectively)
Description | Sparsentan is a first-in-class orally active and highly potent dual endothelin A and angiotensin II receptor antagonist(Ki of 9.3 and 0.8 nM, respectively) |
Targets&IC50 | Human endothelin A:9.3 nM(ki) , Human angiotensin II:0.8 nM(ki) , Rat angiotensin II:0.4 nM(ki) |
Synonyms | DARA-a, RE-021 |
Molecular Weight | 592.76 |
Formula | C32H40N4O5S |
CAS No. | 254740-64-2 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 240 mg/mL (404.89 mM), Need ultrasonic
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Sparsentan 254740-64-2 G蛋白偶联受体 内分泌与激素 RAAS Endothelin Receptor RE 021 Inhibitor inhibit Angiotensin Receptor RE-021 RE021 DARA-a inhibitor